Pirtobrutinib + R-CHOP for Untreated Non-GCB DLBCL

Clinical trial NCT07744737 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07744737
Sponsor: Changzhou No.2 People's Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

DLBCL - Diffuse Large B Cell Lymphoma R-CHOP Chemotherapy Pirtobrutinib

Start date: 2026-07-30
Primary completion: 2027-07-30
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.